The influence of xerostomia after radiotherapy on quality of life
Top Cited Papers
- 6 July 2007
- journal article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 16 (2) , 171-179
- https://doi.org/10.1007/s00520-007-0300-5
Abstract
Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life. A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancer patients, more than 6 months after radiotherapy and without evidence of disease. The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy. Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomiaSupportive Care in Cancer, 2007
- Radiation‐induced xerostomia in patients with head and neck cancerCancer, 2006
- Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the NetherlandsEuropean Journal Of Cancer, 2006
- Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositisHead & Neck, 2005
- Dose–response relationships within the parotid gland after radiotherapy for head and neck cancerRadiotherapy and Oncology, 2004
- Speech Intelligibility and Quality of Life in Head and Neck Cancer SurvivorsThe Laryngoscope, 2004
- Letters to the editorHead & Neck, 2003
- Quality of life and oral function in patients treated with radiation therapy for head and neck cancerHead & Neck, 2001
- Quality of Life in Head and Neck CancerThe Laryngoscope, 2000
- Factors Related to Quality of Life and Functional Status in 50 Patients With Head and Neck CancerThe Laryngoscope, 1996